Sorry, I was referring to another stock, SYN that Seal is
Sorry, I was referring to another stock, SYN that Seal is invested in, me too.
CTIX may close out 2013 with a profit for the year after all! Bet those who sold in the 1.40 and 1.50s are feeling a little pain! LOL..... So much for the stock analysis that predicted $1.00
If Seal is reading this, how does the news with SYN sit with you?
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...
Continue Reading
A Battle Cry Against Hunger Look, there’s no shortage of firms tossing around cash as PR stunts. But Duke Energy’s latest campaign to tackle hunger in South Carolina right at the root is one effort that seems to echo with a real bang. Coming at us with more than $500,000 in support for nearly 70 organizations across the state, they’re not just talking the talk. This...
Continue Reading
A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...
Continue Reading
Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....
Continue Reading
Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...
Continue Reading
Wheels Up's New Horizons with Phenom 300E Jets Wheels Up Experience Inc. (NYSE: UP) just dropped a bombshell with their plan to purchase six spanking new Phenom 300E jets from Embraer (NYSE: EMBJ). This ain't just another lease agreement; this is their first-ever direct buy from Embraer, and it's set to add some serious flair to their fleet. Setting the Stage for Growth...
Continue Reading
Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...
Continue Reading
An Uneven Start to Borussia Dortmund's Financial Year Every finance year kickoff has its tales, and Borussia Dortmund's start for 2026/2027 is no different. The embattled team has been juggling a mixed bag of financial outcomes, darting through initial challenges with a revenue that hovers slightly above the previous year's mark. Revenue crept up to EUR 107.4 million,...
Continue Reading
Drone Composites: A Market Poised for Surge Strap in, folks! The drone composites market is gearing up for a wild ride, projected to nearly double from $7.06 billion in 2026 to a whopping $13.59 billion by 2031. That's a solid 14% compound annual growth rate (CAGR) for those keeping score at home. With those numbers, it's no wonder market players are strategizing hard to...
Continue Reading
A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...
Continue Reading
Top 5 Most Recently Viewed Articles
Christine Russell's Stock Option Exercise at eGain In a recent filing with the SEC, it was disclosed that Christine Russell, a Board Member at eGain, executed an options exercise that ended up realizing no monetary gain due to the exercise price being set at $0.0. This move raised eyebrows among investors as it was worth 0 shares of the company, painted against eGain's...
Continue Reading
Performance Highlights from Crown Castle's Q3 2024 Crown Castle International Corp. (NYSE: CCI) delivered a commendable performance in its third quarter of 2024, showcasing its resilience in the competitive telecommunications sector. The company maintained its full-year outlook for adjusted EBITDA and AFFO while anticipating consolidated organic revenue growth of...
Continue Reading
Overview of Recent Trading Activity at Alliance Pharma In the landscape of finance, keeping track of significant trading activities is paramount for stakeholders. This is especially true for companies like Alliance Pharma plc, known for their strategic initiatives that directly impact the market. Recently, important disclosures related to trading have captured the...
Continue Reading
Wall Street's Historic Rally Wall Street has witnessed an impressive rally lately, with significant benchmarks like the S&P 500 and the Nasdaq 100 soaring to all-time highs. This upward momentum is largely attributed to robust corporate earnings, positive economic indicators, and a growing enthusiasm for technology, particularly driven by advancements in artificial...
Continue Reading
Invitation to Q3 2025 Financial Results Presentation AKVA group ASA is excited to extend an invitation for the presentation of its Q3 2025 financial results. This is an excellent opportunity for investors, stakeholders, and anyone interested in understanding the company's performance during this period. Presentation Details The presentation is scheduled for Friday,...
Continue Reading